Report questioning intensive blood glucose control in type 2 diabetes sparks rowBMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d4609 (Published 19 July 2011) Cite this as: BMJ 2011;343:d4609
- Ned Stafford
The German Diabetes Association (DDG) has criticised a so called “rapid report” from Germany’s drug evaluation agency suggesting that the evidence on the health benefits of lowering blood glucose concentrations to near normal in patients with type 2 diabetes is inconclusive.
The report, published on 5 July by the Institute for Quality and Efficiency in Health Care (known in Germany as IQWIG), said that the question of whether patients with type 2 diabetes mellitus benefit from “intensive blood glucose control” remains “unanswered.” It added, “The studies currently available provide indications of a benefit but also of potential harm.”
The DDG issued a press release on the report from IQWIG, the German equivalent of the United Kingdom’s National Institute for Health and Clinical …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial